Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2017 Filed Apr 3, 2017 18:14 UTC |
Cranston Lynda SarahDirector
|
OtherCommon Stock | 71 | $3.20 | $227.20 |
DisclosureSEC source: 0001213900-17-003268 · f4033117cranston_delmar.xml · nonDerivative · entry 1 Cranston Lynda Sarah · CIK 0001633660 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 261 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Shares are held by J.G. Cranston & Associates, Inc. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 22:16 UTC |
Praill Anthony ScottChief Financial Officer
|
OtherCommon Stock | 211 | $3.20 | $675.20 |
DisclosureSEC source: 0001213900-17-003272 · f4033117praill_delmar.xml · nonDerivative · entry 1 Praill Scott · CIK 0001332948 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,777 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 22:15 UTC |
Mohr ErichDirector
|
OtherCommon Stock | 528 | $3.20 | $1,689.60 |
DisclosureSEC source: 0001213900-17-003270 · f4033117mohr_delmar.xml · nonDerivative · entry 1 Mohr Erich · CIK 0001298170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,943 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 22:13 UTC |
Brown Dennis MDirector · Chief Scientific Officer
|
OtherCommon Stock | 169 | $3.20 | $540.80 |
DisclosureSEC source: 0001213900-17-003266 · f4033117brown_delmar.xml · nonDerivative · entry 1 Brown Dennis M · CIK 0001569520 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 885,008 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Includes 347,508 shares of the Issuer's common stock owned directly by reporting person and 537,500 shares of the Issuer's common stock held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares. Read SEC document |
| March 31, 2017 Filed Apr 3, 2017 22:12 UTC |
Bell John KDirector
|
OtherCommon Stock | 282 | $3.20 | $902.40 |
DisclosureSEC source: 0001213900-17-003264 · f4033117bell_delmar.xml · nonDerivative · entry 1 Bell John K · CIK 0001569585 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 35,288 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Shares are held by Onbelay Capital Inc. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:39 UTC |
TOTH ROBERT JOSEPH JRDirector
|
OtherCommon Stock | 74 | $3.20 | $236.80 |
DisclosureSEC source: 0001213900-17-003330 · f4033117toth_delmar.xml · nonDerivative · entry 1 TOTH ROBERT JOSEPH JR · CIK 0001585020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,147 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:22 UTC |
BACHA JEFFREYDirector · Chief Executive Officer
|
OtherCommon Stock | 176 | $3.20 | $563.20 |
DisclosureSEC source: 0001213900-17-003327 · f4033117bacha_delmar.xml · nonDerivative · entry 1 BACHA JEFFREY · CIK 0001432149 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,145 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 21:25 UTC | GrantOptions (Right to Buy) · Derivative | 37,400 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001213900-17-001713 · f4021717praill_delmarpharma.xml · derivative · entry 1 Praill Scott · CIK 0001332948 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,400 Underlying: Common Stock · 37,400 shares Expires 2027-02-17 F1 · derivative.exercise_date: The options vest in equal monthly installments over three years. Read SEC document |
|
| February 17, 2017 Filed Feb 22, 2017 21:24 UTC |
BACHA JEFFREYDirector · CEO
|
GrantOptions (Right to Buy) · Derivative | 93,600 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001213900-17-001711 · f4021717bacha_delmarpharma.xml · derivative · entry 1 BACHA JEFFREY · CIK 0001432149 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,600 Underlying: Common Stock · 93,600 shares Expires 2027-02-17 F1 · derivative.exercise_date: The options vest in equal monthly installments over three years. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 21:23 UTC |
Brown Dennis MDirector · Chief Scientific Officer
|
GrantOptions (Right to Buy) · Derivative | 93,600 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001213900-17-001708 · f4021717brown_delmarpharma.xml · derivative · entry 1 Brown Dennis M · CIK 0001569520 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,600 Underlying: Common Stock · 93,600 shares Expires 2027-02-17 F1 · derivative.exercise_date: The options vest in equal monthly installments over three years. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 16:44 UTC |
BACHA JEFFREYDirector · CEO
|
PurchaseCommon Stock | 4,000 | $5.00 | $20,000.00 |
DisclosureSEC source: 0001213900-17-000873 · f4020117bacha_delamar.xml · nonDerivative · entry 1 BACHA JEFFREY · CIK 0001432149 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,969 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:31 UTC |
Brown Dennis MDirector · Chief Scientific Officer
|
ConversionWarrants (Right to buy) · Derivative | 125,000 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0001213900-17-000886 · f4013117brown_delmarpharm.xml · derivative · entry 2 Brown Dennis M · CIK 0001569520 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The exercise price of the warrants was CDN $2.00. $1.5366 represents the exercise price in USD based on the exchange rate as of the exercise date. F2 · ownership.nature: Warrants were held by Valent Technologies LLC. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:31 UTC |
Brown Dennis MDirector · Chief Scientific Officer
|
ConversionCommon Stock | 125,000 | $1.54 | $192,075.00 |
DisclosureSEC source: 0001213900-17-000886 · f4013117brown_delmarpharm.xml · nonDerivative · entry 1 Brown Dennis M · CIK 0001569520 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 884,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The exercise price of the warrants was CDN $2.00. $1.5366 represents the exercise price in USD based on the exchange rate as of the exercise date. F1 · ownership.nature: Includes 347,339 shares of the Issuer's common stock owned directly by reporting person and 537,500 shares of the Issuer's common stock held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 18:55 UTC |
Brown Dennis MDirector · Chief Scientific Officer
|
OtherCommon Stock | 169 | $3.20 | $540.80 |
DisclosureSEC source: 0001213900-17-000023 · f4123116brown_delmar.xml · nonDerivative · entry 1 Brown Dennis M · CIK 0001569520 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 759,839 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Includes 347,339 shares of the Issuer's common stock owned directly by reporting person and 412,500 shares of the Issuer's common stock held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 18:54 UTC |
Praill Anthony ScottChief Financial Officer
|
OtherCommon Stock | 211 | $3.20 | $675.20 |
DisclosureSEC source: 0001213900-17-000020 · f4123116praill_delmar.xml · nonDerivative · entry 1 Praill Scott · CIK 0001332948 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,566 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 13:54 UTC |
Cranston Lynda SarahDirector
|
OtherCommon Stock | 71 | $3.20 | $227.20 |
DisclosureSEC source: 0001213900-17-000022 · f4123116cranston_delmar.xml · nonDerivative · entry 1 Cranston Lynda Sarah · CIK 0001633660 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 190 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Shares are held by J.G. Cranston & Associates, Inc. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 18:57 UTC |
BACHA JEFFREYDirector · CEO
|
OtherCommon Stock | 176 | $3.20 | $563.20 |
DisclosureSEC source: 0001213900-17-000025 · f4123116bacha_delmar.xml · nonDerivative · entry 1 BACHA JEFFREY · CIK 0001432149 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,969 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 18:55 UTC |
Bell John KDirector
|
OtherCommon Stock | 282 | $3.20 | $902.40 |
DisclosureSEC source: 0001213900-17-000024 · f4123116bell_delmar.xml · nonDerivative · entry 1 Bell John K · CIK 0001569585 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 35,006 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Shares are held by Onbelay Capital Inc. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 18:54 UTC |
Mohr ErichDirector
|
OtherCommon Stock | 528 | $3.20 | $1,689.60 |
DisclosureSEC source: 0001213900-17-000021 · f4123116mohr_delmar.xml · nonDerivative · entry 1 Mohr Erich · CIK 0001298170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,415 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 18:53 UTC |
TOTH ROBERT JOSEPH JRDirector
|
OtherCommon Stock | 74 | $3.20 | $236.80 |
DisclosureSEC source: 0001213900-17-000019 · f4123116toth_delmar.xml · nonDerivative · entry 1 TOTH ROBERT JOSEPH JR · CIK 0001585020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,073 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 22:20 UTC |
Praill Anthony ScottChief Financial Officer
|
OtherCommon Stock | 211 | $3.20 | $675.20 |
DisclosureSEC source: 0001213900-16-017277 · f4100316praill_delmarpharma.xml · nonDerivative · entry 1 Praill Scott · CIK 0001332948 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,355 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 13:57 UTC |
Cranston Lynda SarahDirector
|
OtherCommon Stock | 71 | $3.20 | $227.20 |
DisclosureSEC source: 0001213900-16-017304 · f4100316cranston_delmar.xml · nonDerivative · entry 1 Cranston Lynda Sarah · CIK 0001633660 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 119 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Share are held by J.G. Cranston & Associates, Inc. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 18:14 UTC |
BACHA JEFFREYDirector · CEO
|
OtherCommon Stock | 176 | $3.20 | $563.20 |
DisclosureSEC source: 0001213900-16-017306 · f4100316bacha_delmar.xml · nonDerivative · entry 1 BACHA JEFFREY · CIK 0001432149 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,793 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 17:02 UTC |
TOTH ROBERT JOSEPH JRDirector
|
OtherCommon Stock | 74 | $3.20 | $236.80 |
DisclosureSEC source: 0001213900-16-017300 · f4100316toth_delmarpharma.xml · nonDerivative · entry 1 TOTH ROBERT JOSEPH JR · CIK 0001585020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,999 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 16:32 UTC |
Brown Dennis MDirector · Chief Scientific Officer
|
OtherCommon Stock | 169 | $3.20 | $540.80 |
DisclosureSEC source: 0001213900-16-017298 · f4100316brown_delmarpharm.xml · nonDerivative · entry 1 Brown Dennis M · CIK 0001569520 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 759,670 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Includes 347,170 shares of the Issuer's common stock owned directly by reporting person and 412,500 shares of the Issuer's common stock held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 15:12 UTC |
Bell John KDirector
|
OtherCommon Stock | 282 | $3.20 | $902.40 |
DisclosureSEC source: 0001213900-16-017293 · f4100316bell_delmarpharm.xml · nonDerivative · entry 1 Bell John K · CIK 0001569585 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 34,724 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F2 · ownership.nature: Shares are held by Onbelay Capital Inc. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 14:20 UTC |
Mohr ErichDirector
|
OtherCommon Stock | 528 | $3.20 | $1,689.60 |
DisclosureSEC source: 0001213900-16-017291 · f4100316mohr_delmarpharm.xml · nonDerivative · entry 1 Mohr Erich · CIK 0001298170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887 F1 · kind: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. F1 · price: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.